Three things to know:
1. Mr. Beyer previously served in several executive leadership roles at Stryker, K2M and Johnson & Johnson.
2. He comes with more than 25 years of experience in the spinal surgery industry.
3. Mr. Beyer will lead Safe Orthopaedics’ sales and management efforts. He is tasked with maintaining the strong commercial growth achieved by the company in 2019.
More articles on devices:
‘The most expensive drug in the world’ — 10 details on Novartis’ $2.1M drug for spinal muscular atrophy
Zimmer Biomet 2019 sales hit $8 billion: 7 things to know
8 orthopedic practices partnering with hospitals, health systems
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.